Cargando…

Carcinoembryonic antigen levels are increased with pulmonary output in pulmonary hypertension due to congenital heart disease

OBJECTIVE: Pulmonary artery hypertension (PAH) is a severe complication of congenital heart disease (CHD). Monitoring of pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) is essential during follow-up. This retrospective study aimed to examine carcinoembryonic antigen (CEA) a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zi-yang, Yang, Kaixun, Zhao, Dongling, Luo, Zhou, Yin, Chengbin, Zhou, Jimei, Chen, Caojin, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683927/ https://www.ncbi.nlm.nih.gov/pubmed/33203284 http://dx.doi.org/10.1177/0300060520964378

Ejemplares similares

High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension
por: Luo, Dongling, et al.
Publicado: (2020)

Association of nutritional status and mortality risk in patients with primary pulmonary hypertension
por: Luo, Dongling, et al.
Publicado: (2022)

Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis
por: Wang, Ran, et al.
Publicado: (2023)

Congenital coronary artery fistulas complicated with pulmonary hypertension: Analysis of 211 cases
por: Said, Salah AM
Publicado: (2016)

Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers
por: Liu, Hai-Ning, et al.
Publicado: (2023)

Pathogenesis of pulmonary hypertension caused by left heart disease
por: Xiao, Mingzhu, et al.
Publicado: (2023)

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer
por: Cai, Du, et al.
Publicado: (2019)

NMR-Based Metabolomic Analysis of Plasma in Patients with Adult Congenital Heart Disease and Associated Pulmonary Arterial Hypertension: A Pilot Study
por: Xu, Beizhu, et al.
Publicado: (2022)

Healthcare status of adults with pulmonary hypertension due to congenital heart disease
por: Busse, Amely J., et al.
Publicado: (2022)

Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer
por: Cheong, Chinock, et al.
Publicado: (2020)

Pulmonary hypertension in congenital heart disease
por: Pascall, Emma, et al.
Publicado: (2018)

Treatment with neurohormonal inhibitors and prognostic outcome in pulmonary arterial hypertension with risk factors for left heart disease
por: Scagliola, Riccardo, et al.
Publicado: (2022)

Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
por: Schuuring, M. J., et al.
Publicado: (2011)

Endothelial dysfunction and atherosclerosis in children with irreversible pulmonary hypertension due to congenital heart disease
por: Çiftel, Murat, et al.
Publicado: (2012)

lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease
por: Yang, Qi, et al.
Publicado: (2023)

Automatic echocardiographic evaluation of the probability of pulmonary hypertension using machine learning
por: Liao, Zuwei, et al.
Publicado: (2023)

Prognostic significance of pretreatment serum carcinoembryonic antigen levels in gastric cancer with pathological lymph node-negative: A large sample single-center retrospective study
por: Xiao, Jun, et al.
Publicado: (2017)

Pulmonary hypertension due to left heart disease
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

Value of the neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease complicated with pulmonary hypertension
por: Jiang, Tingting, et al.
Publicado: (2023)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
por: Das, Bibhuti B., et al.
Publicado: (2020)

Editorial: Pulmonary hypertension associated with congenital heart disease
por: He, Siyi, et al.
Publicado: (2023)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease
por: Alhabeeb, Waleed, et al.
Publicado: (2014)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
por: Lopes, Antonio, et al.
Publicado: (2014)

Controversies in pulmonary hypertension due to left heart disease
por: Cheli, Martino, et al.
Publicado: (2015)

Effect of Dexmedetomidine on Pulmonary Artery Pressure in Children with Congenital Heart Disease and Pulmonary Hypertension
por: Kanchi, Muralidhar, et al.
Publicado: (2020)

Comprehensive assessments of pulmonary circulation in children with pulmonary hypertension associated with congenital heart disease
por: Muneuchi, Jun, et al.
Publicado: (2022)

Respiratory Microbiome Profile of Pediatric Pulmonary Hypertension Patients Associated With Congenital Heart Disease
por: Wang, Ting, et al.
Publicado: (2022)

Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy
por: Niznansky, Matus, et al.
Publicado: (2021)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Pulmonary hypertension in infants with congenital heart defects: are leukotrienes involved?
por: Serraf, A., et al.
Publicado: (1997)

Anesthetic management of pediatric with congenital heart disease with pulmonary hypertension
por: Singh, Dipika, et al.
Publicado: (2014)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Echocardiography for the Assessment of Pulmonary Hypertension and Congenital Heart Disease in the Young
por: Meinel, Katharina, et al.
Publicado: (2020)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

Usefulness of the Duke Activity Status Index to Assess Exercise Capacity and Predict Risk Stratification in Patients with Pulmonary Arterial Hypertension
por: Zhou, Haofeng, et al.
Publicado: (2023)

MicroRNA-204 as an Indicator of Severity of Pulmonary Hypertension in Children with Congenital Heart Disease Complicated with Pulmonary Hypertension
por: Li, Xu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d1627g8k27mhenvg6o76u4432l